# Virtual screening of Withania somnifera phytochemicals identifies scopoletin and linoleic acid as predicted dual-target AChE/BACE1 candidates for alzheimer’s disease

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s41598-026-71874-8) · 2026-11-07 · Life
Page: https://themorning.science/story/virtual-screening-of-withania-somnifera-phytochemicals-identifies-scopoletin-and-3a3575fc1fca815c
Kind: research · Impact: low

## In brief

- A virtual screening study examined Withania somnifera phytochemicals against AChE and BACE1, two enzyme targets in Alzheimer's disease.
- The study predicts scopoletin and linoleic acid as dual-target candidates; these are computational predictions, not lab or clinical results.

## Why it matters

The work is an early computational screen that narrows down candidate compounds for Alzheimer's drug research. Predicted binding does not establish efficacy or safety, so the findings need experimental validation before they mean anything for patients.

## Timeline

- 2026-11-07: Virtual screening results published on nature.com

## Coverage

- [Virtual screening of Withania somnifera phytochemicals identifies scopoletin and linoleic acid as predicted dual-target AChE/BACE1 candidates for alzheimer’s disease](https://www.nature.com/articles/s41598-026-71874-8) — Biological sciences : nature.com subject feeds, 2026-11-07

Tags: alzheimers, virtual-screening, drug-discovery, phytochemicals, withania-somnifera

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science